🟢 Moleculin Biotech is trading 8.59% up today — following sharp 32.71% decline

Moleculin Biotech is trading 8.59% up at $0.56 following a sharp 32.71% decline, with no confirmed company-specific catalyst identified.

• It closed at $0.52 on September 21, 2026.
• No new company-specific announcement was identified for September 22, 2026; the latest material disclosure remains Nasdaq’s minimum-bid-price delisting notice, citing 30 consecutive business days below $1.00 and the company’s planned hearing request.
• Broader market support was modest, with Nasdaq up 0.48%.